IP Library Granted Patent US 9,339,475
Granted Patent B2
US 9,339,475 · App. 14/170,927 · Granted May 17, 2016

Spatial arrangement of particles in a drinking device for oral delivery of pharmaceuticals

Inventors: Jonathan David Bortz (St. Louis, MO); Yury Lagoviyer (Olivette, MO); Paul Timothy Brady (St. Louis, MO)
Assignee: Particle Dynamics International, LLC
A61K9/50A61K9/0095
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,339,475
App. No.
14/170,927
Granted
May 17, 2016
Kind
B2
Abstract

The present invention relates to spatially arranging a plurality of particles in a device for the oral delivery of a pharmaceutical. In particular, the plurality of particles is utilized for the oral delivery of a pharmaceutical to a subject via the drinking device.

Claims (22)

1. A method of delivering a pharmaceutically active agent to a subject, the method comprising:

a subject imbibing an aqueous fluid using a drinking device, wherein the drinking device comprises a hollow tube having two ends, a plurality of particles, each of the plurality of particles comprising a pharmaceutically active agent, and the device further comprising a plurality of particle containment elements that restrain the particles within the hollow tube while the subject imbibes the aqueous fluid and a dosage comprising an effective amount of the pharmaceutically active agent is orally delivered to the subject as fluid flows over the plurality of particles during said imbibing, wherein the particles are spatially arranged within the device to achieve a specific flow resistance not greater than about 50 Torr/mm such that a dosage comprising an effective amount of the pharmaceutically active agent is orally delivered to the subject as fluid flows over the particles during said imbibing, wherein each of the plurality of particles comprises an inner core comprising an inert material, and an outer layer containing the active agent and surrounding the inner core, the inner cores remaining within the hollow tube after said imbibing, and wherein the inner cores are insoluble when contacted with an aqueous medium.

2. The method of claim 1 wherein the drinking device is in the form of a straw.

3. The method of claim 2 wherein the particles comprising a pharmaceutically active agent are spatially arranged at the end of the straw where the subject imbibes the aqueous fluid.

4. The method of claim 1 wherein the dosage of the pharmaceutically active agent is orally administered after the subject has imbibed from about 10 to about 50 mL of the aqueous fluid.

5. The method of claim 1 , wherein the dosage of the pharmaceutically active agent is orally administered after the subject has imbibed at least about 10 mL of the aqueous fluid.

6. The method of claim 1 wherein the particles release the pharmaceutically active agent within from about 1 second to about 5 minutes after being contacted with the aqueous fluid.

7. A method of delivering a pharmaceutically active agent to a subject, the method comprising:

a subject imbibing an aqueous fluid using a drinking device, wherein the drinking device comprises a hollow tube having two ends, a plurality of particles, each of the plurality of particles comprising a pharmaceutically active agent and an indicator coating, and the device further comprising a plurality of particle containment elements that restrain the particles within the hollow tube while the subject imbibes the aqueous fluid and a dosage comprising an effective amount of the pharmaceutically active agent is orally delivered to the subject as fluid flows over the plurality of particles during said imbibing, wherein each of the plurality of particles comprises an inner core comprising an inert material, an outer layer surrounding the inner core and containing the active agent, the indicator coating surrounding the inner core and in contact with the outer layer, the inner cores remaining within the hollow tube after said imbibing and wherein the inner cores are insoluble when contacted with an aqueous medium.

8. The method of claim 7 wherein the drinking device is in the form of a straw.

9. The method of claim 8 wherein the particles comprising a pharmaceutically active agent are spatially arranged at the end of the straw where the subject imbibes the aqueous fluid.

10. The method of claim 7 wherein the dosage of the pharmaceutically active agent is orally administered after the subject has imbibed from about 10 to about 50 mL of the aqueous fluid.

11. The method of claim 7 , wherein the dosage of the pharmaceutically active agent is orally administered after the subject has imbibed at least about 10 mL of the aqueous fluid.

12. The method of claim 7 wherein the particles release the pharmaceutically active agent within from about 1 second to about 5 minutes after being contacted with the aqueous fluid.

13. The method of claim 7 wherein the indicator coating comprises a color such that when the dosage of the pharmaceutically active agent is released from the particles a color becomes visible.

14. The method of claim 7 wherein the particles have a tensile strength of not less than about 0.01 MPa and a friability of not more than about 15%.

15. The method of claim 14 wherein the drinking device is in the form of a straw.

16. The method of claim 15 wherein the particles comprising a pharmaceutically active agent are spatially arranged at the end of the straw where the subject imbibes the aqueous fluid.

17. The method of claim 14 wherein the dosage of the pharmaceutically active agent is orally administered after the subject has imbibed from about 10 to about 50 mL of the aqueous fluid.

18. The method of claim 14 , wherein the dosage of the pharmaceutically active agent is orally administered after the subject has imbibed at least about 10 mL of the aqueous fluid.

19. The method of claim 14 wherein the particles release the pharmaceutically active agent within from about 1 second to about 5 minutes after being contacted with the aqueous fluid.

20. The method of claim 14 wherein the particles have a tensile strength ranging from about 0.1 to about 10 MPa, and a friability ranging from about 0% to about 5%.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Oct 8, 2019
From: FIFTH THIRD BANK
To: PARTICLE DYNAMICS INTERNATIONAL, LLC
Reel/Frame 050654/0207 →
SECURITY INTEREST Recorded Oct 8, 2019
From: PARTICLE DYNAMICS INTERNATIONAL, LLC
To: FIRST MERCHANTS BANK
Reel/Frame 050654/0840 →
SECURITY INTEREST Recorded Oct 3, 2019
From: PARTICLE DYNAMICS INTERNATIONAL, LLC
To: FARRAGUT SBIC FUND II, LP
Reel/Frame 050620/0723 →
FIRST AMENDMENT TO INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded May 31, 2017
From: PARTICLE DYNAMICS INTERNATIONAL, LLC
To: FIFTH THIRD BANK
Reel/Frame 042642/0214 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 13, 2014
From: BORTZ, JONATHAN DAVID; LAGOVIYER, YURY; BRADY, PAUL TIMOTHY
To: PARTICLE DYNAMICS INTERNATIONAL, LLC
Reel/Frame 032880/0673 →
Continuity (3)
Continuation 12032964 · Feb 18, 2008
Provisional Application 60894759 · Mar 14, 2007
Related Publication 20140212505A1 · Jul 31, 2014